RM

Ram Mohan Reddy Kayathi

Active Director Director DIN 09227487
DIN 09227487 First appointment Jul 2021 Primary industry Business Services
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Ram Mohan Reddy Kayathi

Data last updated:

Ram Mohan Reddy Kayathi is a Director at Rolven Pharmaceuticals Private Limited (since 2021). The company operates in Business Services.

DIN 09227487
Primary Designation Director
Industry Business Services
First Appointment 05 Jul 2021
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director05 Jul 20212021Active

Board colleagues of Ram Mohan Reddy Kayathi

NameDINCompanyDesignation
Rajith Reddy Veerareddy09227486Rolven Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Rolven Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Ram Mohan Reddy Kayathi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ram Mohan Reddy Kayathi

Ram Mohan Reddy Kayathi currently holds 1 directorship: Rolven Pharmaceuticals Private Limited (Director, since 05 Jul 2021).

Ram Mohan Reddy Kayathi was first appointed on 05 Jul 2021 as Director at Rolven Pharmaceuticals Private Limited.

The current boards of Ram Mohan Reddy Kayathi's companies include Rajith Reddy Veerareddy (Rolven Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available